Chronic opioid therapy and sleep: An American academy of sleep medicine position statement

Ilene M. Rosen, R. Nisha Aurora, Douglas B. Kirsch, Kelly A. Carden, Raman K. Malhotra, Kannan Ramar, Fariha Abbasi-Feinberg, David A. Kristo, Jennifer L. Martin, Eric J. Olson, Carol L. Rosen, James A. Rowley, Anita V. Shelgikar

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


There is a complex relationship among opioids, sleep and daytime function. Patients and medical providers should be aware that chronic opioid therapy can alter sleep architecture and sleep quality as well as contribute to daytime sleepiness. It is also important for medical providers to be cognizant of other adverse effects of chronic opioid use including the impact on respiratory function during sleep. Opioids are associated with several types of sleep-disordered breathing, including sleep-related hypoventilation, central sleep apnea (CSA), and obstructive sleep apnea (OSA). Appropriate screening, diagnostic testing, and treatment of opioidassociated sleep-disordered breathing can improve patients' health and quality of life. Collaboration amongmedical providers is encouraged to provide high quality, patient-centered care for people who are treated with chronic opioid therapy.

Original languageEnglish
Pages (from-to)1671-1673
Number of pages3
JournalJournal of Clinical Sleep Medicine
Issue number11
StatePublished - Nov 15 2019


Dive into the research topics of 'Chronic opioid therapy and sleep: An American academy of sleep medicine position statement'. Together they form a unique fingerprint.

Cite this